Effective IT support for manufacturing and business processes is critical to ensure business success and maintaining a competitive advantage.
Lek, d. d., a member of Sandoz Group, Novartis' generic division, is a pioneer in the field of biologics and belongs to the second largest generic drug manufacturer in the world. Slovenian, European and global generic pharmaceutical company develops, manufactures and markets efficient, safe and quality medicines - from standard generic to modern biological ones. The forward-looking company is characterized by its dynamic development and internationalization tendencies. Continuous and intensive growth, characterized by Lek's entire history, has escalated even more in the recent years.